A Multidisciplinary Approach to CAR T-cell Therapy for Adult Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Episode 2

Navigating Treatment Selections for B-ALL: Insights From the Moffitt Cancer Center

Experts discuss the key factors influencing product selection in treatment choices at their center, emphasizing clinical efficacy, patient safety, cost-effectiveness, and personalized care.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: CAR T-cell Therapy for B-ALL
    Now Viewing
    EP. 2: Navigating Treatment Selections for B-ALL: Insights From the Moffitt Cancer Center
    EP. 3: The Multidisciplinary Approach to CAR T-Cell Therapy for B-ALL
    EP. 4: CAR T-Cell Therapy for B-ALL: Roles Within the Multidisciplinary Care Team
    EP. 5: Optimizing Molecular Profiling for B-ALL Treatment
    EP. 6: Multidisciplinary Clinical Perspectives: Factors That Influence CAR T-Cell Sequencing in B-ALL
    EP. 7: Considerations Regarding Bridging Therapy for B-ALL CAR T-Cell Treatment
    EP. 8: Obe-Cel for B-ALL: Insights Regarding Persistence, Toxicity, and Remission
    EP. 9: CAR T-Cell Therapy Decisions in B-ALL: The Role of Obe-Cel in B-ALL Treatment
    EP. 10: Managing Immunotoxicities With CAR T-Cell Therapy for B-ALL
    EP. 11: Treatment Sequencing Decisions for B-ALL: Perspectives From Moffitt Cancer Center
    EP. 12: Future Considerations for Treatment Sequencing in B-ALL

    Video content above is prompted by the following:

    When faced with multiple treatment choices, what factors are of paramount consideration in product selection at your center?

    x